Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache

AimMeningeal nociceptors within the trigeminal ganglion are important contributors to migraine pathogenesis because they transmit pain signals from the dura mater to the central nervous system. As such, pharmacological interventions that target these peripheral neurons might offer new avenues for migraine treatment. In this context, ATP-sensitive potassium (K<sub>ATP</sub>) channels have garnered increasing attention as potential modulators of meningeal nociception. Human experimental studies support this hypothesis, showing that intravenous infusion of levcromakalim, a K<sub>ATP</sub> channel opener, induces migraine attacks in people with migraine and mild, transient headache in healthy adults. However, the precise anatomical site and mechanism of action remain incompletely understood.MethodsTo address these gaps, we conducted <i>in vivo</i> single-unit electrophysiological recordings of 36 meningeal nociceptors (23 Aδ- and 13 C-fibers) in the trigeminal ganglion of anesthetized male and female rats. We measured spontaneous firing rates before and up to four hours after a 20-minute continuous intracarotid infusion of levcromakalim (1.43 mg/kg or 0.14 mg/kg) or vehicle (71.4% ethanol).ResultsLevcromakalim at 1.43 mg/kg activated nine (69%) of 13 nociceptors, compared with one (11%) of nine in the vehicle group (<i>p</i> = 0.012). Activation rates did not differ between Aδ-fibers (6 of 8, 69%) and C-fibers (3 of 6; 50%; <i>p</i> = 1.00), or between male (6 of 8; 75%) and female animals (3 of 5; 60%; <i>p</i> = 0.61). Moreover, levcromakalim at 0.14 mg/kg activated only three (21%) of 14 nociceptors.ConclusionsTaken together, our findings demonstrate that K<sub>ATP</sub> channel opening mediates activation of meningeal nociceptors, providing a mechanistic basis for previous observations in humans. The development of K<sub>ATP</sub> channel blockers might therefore hold therapeutic promise for migraine by inhibiting meningeal nociceptors.

Authors

Institutions

Publication Details

Journal
Cephalalgia
Published
2025-08-01
DOI
https://doi.org/10.1177/03331024251359237
Citations
5
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
7.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache

Rami Burstein, Messoud Ashina, Andrew M. Strassman, Håkan Ashina et al.
5 citations
Cephalalgia
Migraine and Headache Studies
7.36
article

Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache

Rami Burstein, Messoud Ashina, Andrew M. Strassman, Håkan Ashina, Rune H. Christensen
article en
5 citations

Abstract

AimMeningeal nociceptors within the trigeminal ganglion are important contributors to migraine pathogenesis because they transmit pain signals from the dura mater to the central nervous system. As such, pharmacological interventions that target these peripheral neurons might offer new avenues for migraine treatment. In this context, ATP-sensitive potassium (K<sub>ATP</sub>) channels have garnered increasing attention as potential modulators of meningeal nociception. Human experimental studies support this hypothesis, showing that intravenous infusion of levcromakalim, a K<sub>ATP</sub> channel opener, induces migraine attacks in people with migraine and mild, transient headache in healthy adults. However, the precise anatomical site and mechanism of action remain incompletely understood.MethodsTo address these gaps, we conducted <i>in vivo</i> single-unit electrophysiological recordings of 36 meningeal nociceptors (23 Aδ- and 13 C-fibers) in the trigeminal ganglion of anesthetized male and female rats. We measured spontaneous firing rates before and up to four hours after a 20-minute continuous intracarotid infusion of levcromakalim (1.43 mg/kg or 0.14 mg/kg) or vehicle (71.4% ethanol).ResultsLevcromakalim at 1.43 mg/kg activated nine (69%) of 13 nociceptors, compared with one (11%) of nine in the vehicle group (<i>p</i> = 0.012). Activation rates did not differ between Aδ-fibers (6 of 8, 69%) and C-fibers (3 of 6; 50%; <i>p</i> = 1.00), or between male (6 of 8; 75%) and female animals (3 of 5; 60%; <i>p</i> = 0.61). Moreover, levcromakalim at 0.14 mg/kg activated only three (21%) of 14 nociceptors.ConclusionsTaken together, our findings demonstrate that K<sub>ATP</sub> channel opening mediates activation of meningeal nociceptors, providing a mechanistic basis for previous observations in humans. The development of K<sub>ATP</sub> channel blockers might therefore hold therapeutic promise for migraine by inhibiting meningeal nociceptors.

CephalalgiaVol. 45(8)
University of Copenhagen (DK), Beth Israel Deaconess Medical Center (US), Harvard University (US), Copenhagen University Hospital (DK), Rigshospitalet (DK)
Lundbeckfonden, H. Lundbeck A/S, National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 3%
Migraine and Headache Studies
7.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.